Patient Cost-Sharing, Hospitalization Offsets, and the Design of Optimal Health Insurance for the Elderly
49 Pages Posted: 15 Mar 2007 Last revised: 12 Dec 2022
Date Written: March 2007
Abstract
Patient cost-sharing for primary care and prescription drugs is designed to reduce the prevalence of moral hazard in medical utilization. Yet the success of this strategy depends on two factors: the elasticity of demand for those medical goods, and the risk of downstream hospitalizations by reducing access to beneficial health care. Surprisingly, we know little about either of these factors for the elderly, the most intensive consumers of health care in our country. We remedy both of these deficiencies by studying a policy change that raised patient cost-sharing for retired public employees in California. We find that physician office visits and prescription drug utilization are price sensitive, with implied arc-elasticities that are similar to those of the famous RAND Health Insurance Experiment (HIE). However, unlike the HIE, we find substantial "offset" effects in terms of increased hospital utilization in response to the combination of higher copayments for physicians and prescription drugs. These offset effects are concentrated in patients for whom medical care is presumably efficacious: those with a chronic disease. Finally, we find that the savings from increased cost-sharing accrue mostly to the supplemental insurer, while the costs of increased hospitalization accrue mostly to Medicare; thus, there is a fiscal externality associated with cost-sharing increases by supplemental insurers. Our findings suggest that health insurance should be tied to underlying health status, with chronically ill patients facing lower cost-sharing. We also conclude that the externalities to Medicare from supplemental insurance coverage may be more modest than previously suggested due to these offsets.
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
Prescription Drugs, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics
By Zhou Yang, Donna B. Gilleskie, ...
-
Integrated Insurance Design in the Presence of Multiple Medical Technologies
By Dana P. Goldman and Tomas Philipson
-
Is Drug Coverage a Free Lunch? Cross-Price Elasticities and the Design of Prescription Drug Benefits
By Martin Gaynor, Jian Li, ...
-
Is Drug Coverage a Free Lunch? Cross-Price Elasticities and the Design of Prescription Drug Benefits
By Martin Gaynor, Jian Li, ...
-
By Avi Dor and William E. Encinosa
-
By William H. Crown, Ernst R. Berndt, ...
-
Prescription Drug Coverage and Elderly Medicare Spending
By Baoping Shang and Dana P. Goldman
-
By Partha Deb, Pravin K. Trivedi, ...